These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22887853)

  • 1. Anakinra for a refractory case of intermittent hydrarthrosis with a TRAPS-related gene mutation.
    Andrés M; Pascual E
    Ann Rheum Dis; 2013 Jan; 72(1):155. PubMed ID: 22887853
    [No Abstract]   [Full Text] [Related]  

  • 2. Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis.
    Obici L; Meini A; Cattalini M; Chicca S; Galliani M; Donadei S; Plebani A; Merlini G
    Ann Rheum Dis; 2011 Aug; 70(8):1511-2. PubMed ID: 21173015
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of interleukin 1 receptor antagonist (anakinra) on a refractory case of Schnitzler's syndrome.
    Kluger N; Rivière S; Guillot B; Bessis D
    Acta Derm Venereol; 2008; 88(3):287-8. PubMed ID: 18480937
    [No Abstract]   [Full Text] [Related]  

  • 4. IL-1 inhibition with anakinra in a patient with refractory gout.
    Singh D; Huston KK
    J Clin Rheumatol; 2009 Oct; 15(7):366. PubMed ID: 20009976
    [No Abstract]   [Full Text] [Related]  

  • 5. IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease.
    Naumann L; Feist E; Natusch A; Langen S; Krause A; Buttgereit F; Burmester GR
    Ann Rheum Dis; 2010 Feb; 69(2):466-7. PubMed ID: 20107032
    [No Abstract]   [Full Text] [Related]  

  • 6. On-demand treatment with anakinra: a treatment option for selected TRAPS patients.
    Grimwood C; Despert V; Jeru I; Hentgen V
    Rheumatology (Oxford); 2015 Sep; 54(9):1749-51. PubMed ID: 26078218
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrent migratory angioedema as cutaneous manifestation in a familiar case of TRAPS: dramatic response to Anakinra.
    Cattalini M; Meini A; Monari P; Gualdi G; Arisi M; Pelucchi F; Bolognini S; Gattorno M; Calzavara-Pinton PG; Plebani A
    Dermatol Online J; 2013 Nov; 19(11):20405. PubMed ID: 24314780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acitretin- and tumor necrosis factor inhibitor-resistant acrodermatitis continua of hallopeau responsive to the interleukin 1 receptor antagonist anakinra.
    Lutz V; Lipsker D
    Arch Dermatol; 2012 Mar; 148(3):297-9. PubMed ID: 22431771
    [No Abstract]   [Full Text] [Related]  

  • 9. Erosive osteoarthritis of the hand: clinical experience with anakinra.
    Bacconnier L; Jorgensen C; Fabre S
    Ann Rheum Dis; 2009 Jun; 68(6):1078-9. PubMed ID: 19435727
    [No Abstract]   [Full Text] [Related]  

  • 10. Case of anakinra as a steroid-sparing agent for gout inflammation.
    Gratton SB; Scalapino KJ; Fye KH
    Arthritis Rheum; 2009 Sep; 61(9):1268-70. PubMed ID: 19714614
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of the IL-1 receptor antagonist, anakinra, for the treatment of diffuse anterior scleritis in rheumatoid arthritis. Report of two cases.
    Botsios C; Sfriso P; Ostuni PA; Todesco S; Punzi L
    Rheumatology (Oxford); 2007 Jun; 46(6):1042-3. PubMed ID: 17449489
    [No Abstract]   [Full Text] [Related]  

  • 12. Anakinra's efficacy is variable in refractory gout: report of ten cases.
    Chen K; Fields T; Mancuso CA; Bass AR; Vasanth L
    Semin Arthritis Rheum; 2010 Dec; 40(3):210-4. PubMed ID: 20494407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective treatment of steroid refractory adult-onset Still's disease with anakinra.
    Maier J; Birkenfeld G; Pfirstinger J; Schölmerich J; Fleck M; Brühl H
    J Rheumatol; 2008 May; 35(5):939-41. PubMed ID: 18464320
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of intermittent hydrarthrosis with MEFV gene mutations.
    Cañete JD; Aróstegui JI; Queiró R; Sanmartí R; Ballina J; Bosch X; Yagüe J
    Arthritis Rheum; 2006 Jul; 54(7):2334-5. PubMed ID: 16802374
    [No Abstract]   [Full Text] [Related]  

  • 15. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
    Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
    Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anakinra treatment of SAPHO syndrome: short-term results of an open study.
    Wendling D; Prati C; Aubin F
    Ann Rheum Dis; 2012 Jun; 71(6):1098-100. PubMed ID: 22219141
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful therapy with low-dose colchicine in intermittent hydrarthrosis.
    Queiro-Silva R; Tinturé-Eguren T; López-Lagunas I
    Rheumatology (Oxford); 2003 Feb; 42(2):391-2. PubMed ID: 12595650
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of soluble apoptotic markers with impaired left ventricular deformation in patients with rheumatoid arthritis. Effects of inhibition of interleukin-1 activity by anakinra.
    Ikonomidis I; Tzortzis S; Lekakis J; Paraskevaidis I; Dasou P; Parissis J; Nikolaou M; Markantonis SL; Katsimbri P; Skarantavos G; Andreadou I; Anastasiou-Nana M
    Thromb Haemost; 2011 Nov; 106(5):959-67. PubMed ID: 21947196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature.
    Gran JT; Midtvedt Ø; Haug S; Aukrust P
    Scand J Rheumatol; 2011 Jan; 40(1):74-9. PubMed ID: 20936987
    [No Abstract]   [Full Text] [Related]  

  • 20. Higher-dose Anakinra is effective in a case of medically refractory macrophage activation syndrome.
    Kahn PJ; Cron RQ
    J Rheumatol; 2013 May; 40(5):743-4. PubMed ID: 23637382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.